Welcome to our
Media library

Access a range of clinical educational content, to all the clinical content available about for both macula and peripheral treatments, including: clinical articles, clinical videos, treatment guidelines…

SEARCH

Advanced search

Treatment

TYPE OF DOCUMENTS

Type of documents

ADVANCED SEARCH

Treatment

TYPE OF DOCUMENTS

Type of documents
Capture2
Play button

The Role of Subthreshold Laser Therapy in the Age of Intravitreal Injections

08/01/2025
In this video, Dr. Kenneth Fong (OasisEye Specialists, Malaysia) and Dr. Marco Lupidi (Polytechnic University of the Marche, Italy) explore the integration of subthreshold laser therapy in modern ophthalmic practice, particularly in the context of managing diseases like diabetic macular edema and central serous chorioretinopathy (CSC).
Capture
Play button

Subthreshold Laser Therapy: An Overview of Treatment Guidelines & Experience with the Easyret Laser

08/01/2025
Watch Dr Alejandro Filloy, retinal surgeon and specialist at the University Hospital of Tarragona, as he discusses the key aspects of subthreshold laser therapy.
7

Subthreshold laser treatment: To Titrate or Not to Titrate?

22/11/2024
The question of whether to titrate in subthreshold laser treatments has sparked considerable debate among ophthalmologists and researchers. Titration—adjusting the laser’s power settings to gauge the treatment’s effectiveness—has been a common practice to prevent retinal damage.
Controversies on Modern Laser Treatments for Retina and Vitreous
Play button

Controversies on Modern Laser Treatments for Retina and Vitreous

17/10/2024
A panel of experts will discuss two topics: Vitreous Floaters and Opacities: Observation vs intervention / Subthreshold Laser Therapy: To titrate or not to titrate?
RT1

Lasers for Retina

26/02/2024
When to use laser therapy, treatment guidelines, and why it matters.
subli article

SubLiminal Laser Therapy for CSCR

12/12/2023
A new front-line treatment

by

Quantel Medical & Ellex, 2 brands of Lumibird Medical, united with 1 objective: develop cutting-edge technologies for the diagnosis and treatment of dry eye and leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.

Newsletter

"*" indicates required fields

Name
The information collected through this form is recorded and transmitted to the relevant QUANTEL MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to QUANTEL MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at privacy@lumibird.com.
Country*
Personal data compliance
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.
© 2025 Quantel Medical
Share this page by email
Share this page on facebook
Share this page on twitter
Share this page on linkedin